$CRMZ
CREDITRISKMONITOR COM INC

2021 Q1 Form 10-Q Financial Statement

#000114036121017340 Filed on May 14, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $4.133M $3.709M
YoY Change 11.44% 6.09%
Cost Of Revenue $1.628M $1.526M
YoY Change 6.65% 3.9%
Gross Profit $2.505M $2.182M
YoY Change 14.79% 7.68%
Gross Profit Margin 60.61% 58.85%
Selling, General & Admin $2.201M $2.415M
YoY Change -8.88% 11.44%
% of Gross Profit 87.85% 110.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $64.51K $54.11K
YoY Change 19.22% 6.12%
% of Gross Profit 2.58% 2.48%
Operating Expenses $3.893M $3.996M
YoY Change -2.57% 8.36%
Operating Profit $239.8K -$286.9K
YoY Change -183.57% 49.78%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.248K $22.68K
YoY Change -85.68% -44.52%
Pretax Income $243.1K -$264.3K
YoY Change -191.98% 75.36%
Income Tax $55.35K -$65.92K
% Of Pretax Income 22.77%
Net Earnings $187.7K -$198.3K
YoY Change -194.64% 45.34%
Net Earnings / Revenue 4.54% -5.35%
Basic Earnings Per Share $0.02 -$0.02
Diluted Earnings Per Share $0.02 -$0.02
COMMON SHARES
Basic Shares Outstanding 10.72M 10.72M
Diluted Shares Outstanding 10.76M 10.72M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.46M $8.298M
YoY Change 26.1% -1.09%
Cash & Equivalents $10.46M $8.298M
Short-Term Investments $0.00
Other Short-Term Assets $537.9K $624.1K
YoY Change -13.81% -4.76%
Inventory
Prepaid Expenses
Receivables $2.709M $2.195M
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.71M $11.12M
YoY Change 23.33% 1.07%
LONG-TERM ASSETS
Property, Plant & Equipment $584.7K $461.9K
YoY Change 26.59% -84.83%
Goodwill $1.954M $1.954M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $73.40K $46.65K
YoY Change 57.33% 4.82%
Total Long-Term Assets $4.766M $4.799M
YoY Change -0.69% -4.85%
TOTAL ASSETS
Total Short-Term Assets $13.71M $11.12M
Total Long-Term Assets $4.766M $4.799M
Total Assets $18.48M $15.92M
YoY Change 16.09% -0.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $127.2K $186.7K
YoY Change -31.87% -17.53%
Accrued Expenses $1.281M $929.9K
YoY Change 37.8% -4.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.496M
YoY Change
Total Short-Term Liabilities $12.94M $10.45M
YoY Change 23.8% 1.29%
LONG-TERM LIABILITIES
Long-Term Debt $65.69K $0.00
YoY Change
Other Long-Term Liabilities $2.295M $2.496M
YoY Change -8.06% 3.52%
Total Long-Term Liabilities $2.361M $2.496M
YoY Change -5.43% 3.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.94M $10.45M
Total Long-Term Liabilities $2.361M $2.496M
Total Liabilities $15.58M $13.41M
YoY Change 16.21% 1.5%
SHAREHOLDERS EQUITY
Retained Earnings -$26.98M -$27.32M
YoY Change -1.24%
Common Stock $107.2K $107.2K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.899M $2.511M
YoY Change
Total Liabilities & Shareholders Equity $18.48M $15.92M
YoY Change 16.09% -0.79%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $187.7K -$198.3K
YoY Change -194.64% 45.34%
Depreciation, Depletion And Amortization $64.51K $54.11K
YoY Change 19.22% 6.12%
Cash From Operating Activities -$193.0K $60.51K
YoY Change -418.9% -83.33%
INVESTING ACTIVITIES
Capital Expenditures $103.6K $38.05K
YoY Change 172.26% -4.53%
Acquisitions
YoY Change
Other Investing Activities $458.2K
YoY Change
Cash From Investing Activities $354.7K -$38.05K
YoY Change -1032.17% -4.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -193.0K 60.51K
Cash From Investing Activities 354.7K -38.05K
Cash From Financing Activities
Net Change In Cash 161.7K 22.47K
YoY Change 619.7% -93.05%
FREE CASH FLOW
Cash From Operating Activities -$193.0K $60.51K
Capital Expenditures $103.6K $38.05K
Free Cash Flow -$296.6K $22.47K
YoY Change -1420.08% -93.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
127238
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
130089
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2709365
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2557443
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1822485
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1281375
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29760533
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29769955
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15228
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9422
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9422
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15228
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000000
CY2020Q4 us-gaap Assets
Assets
18692542
CY2021Q1 us-gaap Assets
Assets
18478042
CY2020Q4 us-gaap Assets Current
AssetsCurrent
13907484
CY2021Q1 us-gaap Assets Current
AssetsCurrent
13711709
CY2021Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
458237
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10464413
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10302732
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22465
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
161681
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10302732
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8275836
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10464413
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8298301
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10722401
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10722401
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32500000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32500000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10722401
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10722401
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
107224
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
107224
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
277172
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
333432
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-65915
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-56260
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9646407
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9871354
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
197545
CY2021Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
200163
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54112
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64512
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13059862
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12941452
CY2021Q1 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
1495812
CY2021Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
235861
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18478042
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18692542
CY2021Q1 us-gaap Liabilities
Liabilities
15579255
CY2020Q4 us-gaap Liabilities
Liabilities
15990891
CY2020Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
1299007
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2020Q4 us-gaap Goodwill
Goodwill
1954460
CY2021Q1 us-gaap Goodwill
Goodwill
1954460
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
243059
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-264263
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55345
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-65915
CY2020Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
74327
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-10619
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-52015
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
10931
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2851
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
49247
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
151922
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-92840
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-414659
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-541110
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
604048
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
227565
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
278100
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2020Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0
CY2021Q1 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
65688
CY2020Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
262493
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-192971
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
60511
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
187714
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-198348
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38046
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
354652
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3248
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22684
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1627786
CY2020Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1526328
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2094780
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2137559
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
161874
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
165673
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
3893090
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
3995698
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2200031
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2153726
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
7325
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
9216
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-286947
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
239811
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
537931
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
589072
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73399
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
84892
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
103585
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38046
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
458237
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
584748
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
545675
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26978392
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27166106
CY2021Q1 us-gaap Revenues
Revenues
4132901
CY2020Q1 us-gaap Revenues
Revenues
3708751
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2415258
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2200792
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9422
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
15228
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2898787
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2701651
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2694219
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2511099
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10764640
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10722401
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
CREDITRISKMONITOR COM INC
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000315958
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10722401
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true

Files In Submission

Name View Source Status
0001140361-21-017340-index-headers.html Edgar Link pending
0001140361-21-017340-index.html Edgar Link pending
0001140361-21-017340.txt Edgar Link pending
0001140361-21-017340-xbrl.zip Edgar Link pending
brhc10024315_10q.htm Edgar Link pending
brhc10024315_ex31-1.htm Edgar Link pending
brhc10024315_ex31-2.htm Edgar Link pending
brhc10024315_ex32-1.htm Edgar Link pending
brhc10024315_ex32-2.htm Edgar Link pending
crmz-20210331.xml Edgar Link completed
crmz-20210331.xsd Edgar Link pending
crmz-20210331_cal.xml Edgar Link unprocessable
crmz-20210331_def.xml Edgar Link unprocessable
crmz-20210331_lab.xml Edgar Link unprocessable
crmz-20210331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending